In The Spotlight: Urogen Pharma

Shares of Urogen Pharma Ltd. (URGN) are up nearly 70% year-to-date while the iShares Nasdaq Biotechnology ETF (IBB) index has lost 0.8% during the same period.

from RTT - Biotech https://ift.tt/2JnM52Q
via IFTTT